PubRank

Gabriele Fischer

Author PubWeight™ 56.11‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Neonatal abstinence syndrome after methadone or buprenorphine exposure. N Engl J Med 2010 3.84
2 Treatment of opioid-dependent pregnant women: clinical and research issues. J Subst Abuse Treat 2008 1.77
3 Comparative study of the effectiveness of slow-release morphine and methadone for opioid maintenance therapy. Addiction 2005 1.57
4 A randomized, prospective trial of ribavirin 400 mg/day versus 800 mg/day in combination with peginterferon alfa-2a in hepatitis C virus genotypes 2 and 3. Hepatology 2008 1.56
5 Treating pregnant women dependent on opioids is not the same as treating pregnancy and opioid dependence: a knowledge synthesis for better treatment for women and neonates. Addiction 2008 1.51
6 Intrauterine abstinence syndrome (IAS) during buprenorphine inductions and methadone tapers: can we assure the safety of the fetus? J Matern Fetal Neonatal Med 2012 1.43
7 Use of buprenorphine in pregnancy: patient management and effects on the neonate. Drug Alcohol Depend 2003 1.36
8 Management of neonatal abstinence syndrome in neonates born to opioid maintained women. Drug Alcohol Depend 2006 1.31
9 Buprenorphine treatment of opioid-dependent pregnant women: a comprehensive review. Addiction 2012 1.25
10 A Comparison of Buprenorphine + Naloxone to Buprenorphine and Methadone in the Treatment of Opioid Dependence during Pregnancy: Maternal and Neonatal Outcomes. Subst Abuse 2013 1.16
11 Anxiety as a predictor of relapse in detoxified alcohol-dependent patients. Alcohol Alcohol 2002 1.14
12 Unintended pregnancy in opioid-abusing women. J Subst Abuse Treat 2010 1.14
13 Maternal Opioid Treatment: Human Experimental Research (MOTHER)--approach, issues and lessons learned. Addiction 2012 1.13
14 Neonatal outcome following buprenorphine maintenance during conception and throughout pregnancy. Addiction 2003 1.11
15 Cocaine use in Europe - a multi-centre study. Methodology and prevalence estimates. Eur Addict Res 2004 1.10
16 Association between prenatal tobacco exposure and outcome of neonates born to opioid-maintained mothers. Implications for treatment. Eur Addict Res 2009 1.07
17 Quality of life in patients receiving opioid maintenance therapy. A comparative study of slow-release morphine versus methadone treatment. Eur Addict Res 2008 1.03
18 Gender issues in the pharmacotherapy of opioid-addicted women: buprenorphine. J Addict Dis 2010 1.03
19 Cocaine use in Europe - a multi-centre study: patterns of use in different groups. Eur Addict Res 2004 1.03
20 Substance abuse in patients with schizophrenia. Dialogues Clin Neurosci 2006 1.02
21 Co-occurring psychiatric symptoms are associated with increased psychological, social, and medical impairment in opioid dependent pregnant women. Am J Addict 2010 0.95
22 First-trimester fetal heart rate in mothers with opioid addiction. Addiction 2010 0.94
23 Impact of treatment approach on maternal and neonatal outcome in pregnant opioid-maintained women. Hum Psychopharmacol 2011 0.94
24 Characteristics of opioid-using pregnant women who accept or refuse participation in a clinical trial: screening results from the MOTHER study. Am J Drug Alcohol Abuse 2009 0.93
25 Psychopharmacologic management of opioid-dependent women during pregnancy. Am J Addict 2009 0.92
26 Age-related aspects of addiction. Gerontology 2012 0.89
27 Retention rate and side effects in a prospective trial on hepatitis C treatment with pegylated interferon alpha-2a and ribavirin in opioid-dependent patients. Addict Biol 2009 0.89
28 Neonatal neurobehavior effects following buprenorphine versus methadone exposure. Addiction 2012 0.88
29 Molecular cloning and heterologous expression of progesterone 5beta-reductase from Digitalis lanata Ehrh. Phytochemistry 2005 0.88
30 Opioid dependent and pregnant: what are the best options for mothers and neonates? Obstet Gynecol Int 2012 0.88
31 Opioid addiction changes cerebral blood flow symmetry. Neuropsychobiology 2002 0.87
32 Opioid dependence and pregnancy. Curr Opin Psychiatry 2008 0.87
33 Office-based treatment in opioid dependence: a critical survey of prescription practices for opioid maintenance medications and concomitant benzodiazepines in Vienna, Austria. Eur Addict Res 2008 0.86
34 Randomized controlled trials in pregnancy: scientific and ethical aspects. Exposure to different opioid medications during pregnancy in an intra-individual comparison. Addiction 2011 0.85
35 Maintenance therapy with synthetic opioids and driving aptitude. Eur Addict Res 2004 0.84
36 Use of slow-release oral morphine for the treatment of opioid dependence. Eur Addict Res 2005 0.83
37 Relationship between cocaine use and mental health problems in a sample of European cocaine powder or crack users. World Psychiatry 2005 0.83
38 [Cocaine abuse in Vienna and European cities--a multi-center study]. Wien Klin Wochenschr 2006 0.81
39 Opioid plasma concentrations in methadone-and buprenorphine-maintained patients. Addict Biol 2005 0.81
40 Buprenorphine maintenance: office-based treatment with addiction clinic support. Eur Addict Res 2004 0.81
41 Mortality in opioid-maintained patients after release from an addiction clinic. Eur Addict Res 2008 0.81
42 Influence of peak and trough levels of opioid maintenance therapy on driving aptitude. Eur Addict Res 2007 0.80
43 Lessons learned from a comparison of evidence-based research in pregnant opioid-dependent women. Hum Psychopharmacol 2012 0.80
44 [Slow-release morphine hydrochloride for maintenance therapy of opioid dependence]. Wien Klin Wochenschr 2002 0.79
45 [Addiction--who is not affected?]. Wien Med Wochenschr 2005 0.78
46 Characteristics and quality of life of opioid-dependent pregnant women in Austria. Arch Womens Ment Health 2014 0.78
47 Induction of pregnant women onto opioid-agonist maintenance medication: an analysis of withdrawal symptoms and study retention. Drug Alcohol Depend 2013 0.78
48 Opioid dependence during pregnancy: relationships of anxiety and depression symptoms to treatment outcomes. Addiction 2012 0.78
49 Policy drives harm reduction for drug abuse and HIV/AIDS prevention in some developing countries. Drug Alcohol Depend 2007 0.77
50 Are male neonates more vulnerable to neonatal abstinence syndrome than female neonates? Gend Med 2011 0.77
51 Molecular cloning and expression of progesterone 5beta-reductase (5beta-POR) from Isoplexis canariensis. Planta Med 2006 0.76
52 Should pregnant women with substance use disorders be managed differently? Neuropsychiatry (London) 2012 0.76
53 Substance abuse/dependence treatment: a European perspective. Subst Abus 2014 0.75
54 Austria: investigation likely to have serious consequences. Nature 2008 0.75
55 Addiction is a psychiatric disorder - what have we learned from history? Addiction 2012 0.75
56 Shortening of treatment duration in patients with chronic hepatitis C genotype 2 and 3 - impact of ribavirin dose - a randomized multicentre trial. BMC Res Notes 2011 0.75
57 Opioid Maintenance Treatment--A Call for a Joint European Quality Care Approach. Eur Addict Res 2015 0.75
58 [Electrodermal activity in heroin addicts and patients with methadone and morphine substitution]. Wien Med Wochenschr 2003 0.75